These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 708435)

  • 1. The degradation of labelled lanosterol by homogenate of rat liver: evidence for the formation of lithocholic acid from lanosterol without cholesterol as intermediate.
    Wiss O; Wiss V
    Biochem Biophys Res Commun; 1978 Aug; 83(3):857-62. PubMed ID: 708435
    [No Abstract]   [Full Text] [Related]  

  • 2. On metabolic degradations of squalene, lanosterol and cholesterol in rat liver in vivo. Evidence for recycling of metabolites for the synthesis of isoprene compounds.
    Wiss O; Wiss V
    Helv Chim Acta; 1977 Sep; 60(6):1961-6. PubMed ID: 914630
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of squalene, lanosterol, desmosterol, and cholesterol to proteins in brain and liver 105,000 g supernatant fractions: evidence for specific binding sites.
    Johnson RC; Shah SN
    Lipids; 1976 Sep; 11(9):645-51. PubMed ID: 994754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lithocholic acid on cholesterol synthesis and transport in the rat liver.
    Yousef IM; Tuchweber B
    Biochim Biophys Acta; 1984 Dec; 796(3):336-44. PubMed ID: 6509080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4,4'-dimethylcholesta-7,9,14-trienol is an intermediate in the demethylation of dihydroagnosterol.
    Tavares IA; Munday KA; Wilton DC
    Biochem J; 1977 Jul; 166(1):17-20. PubMed ID: 20077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathway for the conversion of dihydroagnosterol into cholesterol in rat liver.
    Tavares IA; Munday KA; Wilton DC
    Biochem J; 1977 Jul; 166(1):11-5. PubMed ID: 901410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithocholic acid-cholesterol interactions in rat liver plasma membrane fractions.
    Yousef IM; Lewittes M; Tuchweber B; Roy CC; Weber A
    Biochim Biophys Acta; 1984 Dec; 796(3):345-53. PubMed ID: 6509081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of hepatic cholesterol biosynthesis. Effects of a cytochrome P-450 inhibitor on the formation and metabolism of oxygenated sterol products of lanosterol.
    Iglesias J; Gibbons GF
    Biochem J; 1989 Dec; 264(2):495-502. PubMed ID: 2604729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholesterol analogs on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y; Morisaki M; Ikekawa N
    Chem Pharm Bull (Tokyo); 1983 May; 31(5):1765-7. PubMed ID: 6616726
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis of lanosterol analogs with lengthened side chains and their effects on cholesterol biosynthesis from lanosterol.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1984 May; 32(5):1912-8. PubMed ID: 6467473
    [No Abstract]   [Full Text] [Related]  

  • 11. Requirement for a major soluble protein in the conversion of lanosterol to cholesterol by membrane-bound enzymes.
    Song MK; Dempsey ME
    Arch Biochem Biophys; 1981 Oct; 211(2):523-9. PubMed ID: 7305386
    [No Abstract]   [Full Text] [Related]  

  • 12. 5beta-cholestane-3alpha, 27-diol: NAD+ oxidoreductase and 3alpha-hydroxy-5beta-cholestan-27-al; NAD+ oxidoreductase in rat liver extract.
    Tsukiai S
    Hiroshima J Med Sci; 1981 Mar; 30(1):1-7. PubMed ID: 6792166
    [No Abstract]   [Full Text] [Related]  

  • 13. Cholesterol biosynthesis from lanosterol: development of a novel assay method and characterization of rat liver microsomal lanosterol delta 24-reductase.
    Bae SH; Paik YK
    Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):609-16. PubMed ID: 9291139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of lanosterol 14 alpha-demethylation. A requirement for two distinct types of mixed-function-oxidase systems.
    Gibbons FG; Pullinger CR; Mitropoulos KA
    Biochem J; 1979 Nov; 183(2):309-15. PubMed ID: 534498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the in vivo metabolism of mevalonic acid in the normal rat.
    Hellstrom KH; Siperstein MD; Bricker LA; Luby LJ
    J Clin Invest; 1973 Jun; 52(6):1303-13. PubMed ID: 4703220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of 27-nor-24,25-dihydrolanosterol and 23,24,25,26,27-pentanordihydrolanosterol by rat liver homogenate preparations.
    Sato Y; Sonoda Y
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):628-34. PubMed ID: 7094149
    [No Abstract]   [Full Text] [Related]  

  • 17. Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 14-reductase.
    Kim CK; Jeon KI; Lim DM; Johng TN; Trzaskos JM; Gaylor JL; Paik YK
    Biochim Biophys Acta; 1995 Oct; 1259(1):39-48. PubMed ID: 7492613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Turnover of the endogenous free cholesterol of the hepatic cell plasma membrane sinusoids].
    Pascaud A; Auliac P; Pascaud M
    Biochimie; 1979; 61(9):1065-71. PubMed ID: 534664
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro effects of oxygenated lanosterol derivatives on cholesterol biosynthesis from 24,25-dihydrolanosterol.
    Sonoda Y; Sekigawa Y; Sato Y
    Chem Pharm Bull (Tokyo); 1988 Mar; 36(3):966-73. PubMed ID: 3409414
    [No Abstract]   [Full Text] [Related]  

  • 20. Differential effects of cholesterol and lanosterol on artificial membranes.
    Yeagle PL; Martin RB; Lala AK; Lin HK; Bloch K
    Proc Natl Acad Sci U S A; 1977 Nov; 74(11):4924-6. PubMed ID: 270726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.